BI Asset Management Fondsmaeglerselskab’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,629
| Closed | -$1.04M | – | 917 |
|
|
2024
Q4 | $1.04M | Buy |
5,629
+2,975
| +112% | +$549K | 0.01% | 509 |
|
|
2024
Q3 | $523K | Buy |
2,654
+1,890
| +247% | +$372K | 0.01% | 469 |
|
|
2024
Q2 | $158K | Sell |
764
-848
| -53% | -$175K | ﹤0.01% | 578 |
|
|
2024
Q1 | $437K | Sell |
1,612
-604
| -27% | -$164K | 0.01% | 557 |
|
|
2023
Q4 | $524K | Buy |
2,216
+1,340
| +153% | +$317K | 0.01% | 512 |
|
|
2023
Q3 | $172K | Hold |
876
| – | – | ﹤0.01% | 632 |
|
|
2023
Q2 | $184K | Hold |
876
| – | – | ﹤0.01% | 620 |
|
|
2023
Q1 | $177K | Buy |
876
+505
| +136% | +$102K | ﹤0.01% | 606 |
|
|
2022
Q4 | $81K | Buy |
+371
| New | +$81K | ﹤0.01% | 621 |
|